PACMAN-AMI: Addition of Alirocumab Lacks Benefit for Endothelial Function

Alirocumab added to high-intensity statin therapy did not further improve endothelial function in patients with acute myocardial infarction.

Related Keywords

Bern ,Switzerland ,Researchgate Lorenz ,Bern University Hospital Inselspital ,Bern University Hospital , ,Quantitative Flow Ratio ,Cardiovascular Outcomes ,Acute Coronary ,Alleviating Oxidation ,